List of insiders holdings for Catalent Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Zippelius Peter Director | 2022-10-31 17:46:24 | 11,979 4,330,462 | 4,342,441 | Form 4 |
Chiminski John R Executive Chair | 2022-08-26 20:16:30 | 229,888 0 | 229,888 | Form 4 |
GREISCH JOHN J Executive Chair | 2023-09-01 13:52:35 | 143,292 34,000 | 177,292 | Form 4 |
Masanovich Matti SVP, Chief Financial Officer | 2023-07-07 16:35:01 | 117,946 0 | 117,946 | Form 4 |
WALSH MATTHEW M EVP & Chief Financial Officer | 2017-08-28 12:29:43 | 103,703 0 | 103,703 | Form 4 |
Gennadios Aristippos Group Pres. Pharma & Consumer | 2023-12-12 19:28:54 | 96,496 0 | 96,496 | Form 4 |
Maselli Alessandro President & CEO | 2023-12-12 19:27:27 | 87,938 0 | 87,938 | Form 4 |
Joseph Wetteny SVP & Chief Financial Officer | 2021-02-18 09:56:20 | 79,227 0 | 79,227 | Form 4 |
Johnson Sharon See Remarks | 2017-04-27 11:02:19 | 77,645 0 | 77,645 | Form 4 |
Fasman Steven L EVP & Chief Admin Officer | 2023-12-12 19:11:23 | 75,423 0 | 75,423 | Form 4/A |
Leonard Stephen See Remarks | 2016-07-28 19:21:12 | 73,140 0 | 73,140 | Form 4 |
MOREL DONALD E JR Director | 2023-10-31 16:27:29 | 65,455 0 | 65,455 | Form 4 |
Arnold Jonathan SVP, CCO & Div. Head BioP Del. | 2023-12-12 18:58:20 | 57,573 0 | 57,573 | Form 4/A |
Kurt Nielsen See Remarks | 2015-02-19 19:28:35 | 57,156 0 | 57,156 | Form 4/A |
Dolan Christine SVP - Product Development | 2017-08-31 10:41:26 | 53,736 0 | 53,736 | Form 4 |
Miyamoto Lance SVP, Human Resources | 2019-03-11 19:31:14 | 46,799 0 | 46,799 | Form 4 |
Downie William SVP, Global Sales & Marketing | 2019-02-20 15:48:52 | 46,662 0 | 46,662 | Form 4 |
BUZY PETER L President, Gene Therapy | 2020-04-13 12:12:26 | 45,950 0 | 45,950 | Form 4 |
Littlejohns Barry President, Biologics & SDD | 2019-08-26 15:49:32 | 45,882 0 | 45,882 | Form 4 |
CLASSON ROLF A Director | 2023-10-31 17:03:31 | 43,321 0 | 43,321 | Form 4 |
STAHL JACK L Director | 2023-10-31 16:25:56 | 43,321 0 | 43,321 | Form 4 |
Evoli Lisa SVP, Chief HR Officer | 2023-08-30 18:20:56 | 42,112 0 | 42,112 | Form 3 |
McErlane David Group President, Biologics | 2023-11-02 21:17:01 | 34,292 0 | 34,292 | Form 3 |
LUCIER GREGORY T Director | 2023-10-31 16:30:32 | 32,251 0 | 32,251 | Form 4 |
Pravda Ricardo Chief Transformation Officer | 2023-12-12 19:21:40 | 30,982 0 | 30,982 | Form 4/A |
Gunther Scott SVP, Quality & Reg. Affairs | 2024-03-19 13:38:36 | 29,506 0 | 29,506 | Form 4 |
CARROLL J MARTIN Director | 2023-10-31 17:04:59 | 28,071 0 | 28,071 | Form 4 |
Balachandran Madhavan Director | 2023-10-31 17:07:40 | 27,441 0 | 27,441 | Form 4 |
Grippo Michael J SVP, Strategy & Corp. Dev. | 2023-12-12 19:05:25 | 25,229 0 | 25,229 | Form 4/A |
Flynn Karen Director | 2023-10-31 17:00:54 | 24,339 0 | 24,339 | Form 4 |
Crane Rosemary A Director | 2023-10-31 17:02:08 | 23,873 0 | 23,873 | Form 4 |
Hopson Ricky Pres. Clinical Dev Supply Div | 2023-12-12 19:24:33 | 22,018 0 | 22,018 | Form 4 |
QUELLA JAMES Director | 2017-08-28 11:31:48 | 20,641 0 | 20,641 | Form 4 |
Castellano Thomas P SVP, Chief Financial Officer | 2022-08-26 20:16:03 | 20,099 0 | 20,099 | Form 4 |
Kreuzburg Christa Director | 2024-01-29 16:09:05 | 18,283 0 | 18,283 | Form 4 |
Schmidt Kay A SVP, Enterprise Functions | 2022-08-26 20:23:59 | 17,388 0 | 17,388 | Form 4 |
BOOTH MELVIN D Director | 2016-08-26 14:56:50 | 16,665 0 | 16,665 | Form 4 |
Roehrhoff Uwe Director | 2017-11-22 16:25:28 | 16,489 0 | 16,489 | Form 4 |
Houlton Scott See Remarks | 2015-09-04 17:39:27 | 16,380 0 | 16,380 | Form 4 |
Zayas Ricardo SVP, Operations, Biologics NA | 2023-08-03 17:17:23 | 16,101 0 | 16,101 | Form 4 |
Boerman Manja Pres. BioModalities Division | 2023-05-03 19:00:37 | 14,414 0 | 14,414 | Form 4 |
Ferraro Joseph Anthony SVP, General Counsel, CCO | 2023-10-19 14:46:54 | 13,755 0 | 13,755 | Form 4 |
Barber Michael J Director | 2023-10-31 17:06:12 | 13,389 0 | 13,389 | Form 4 |
Hatzfeld Michael Chief Accounting Officer | 2024-01-18 20:51:52 | 11,889 0 | 11,889 | Form 4 |
HEGWOOD PAUL W JR President, CSS | 2019-08-26 15:48:26 | 11,848 0 | 11,848 | Form 4 |
Lickfold Charles SVP, CIO | 2023-12-12 19:19:54 | 11,719 0 | 11,719 | Form 4/A |
Hunt Patricia Pres. Consumer Health Div | 2023-12-12 19:17:51 | 11,501 0 | 11,501 | Form 4/A |
Santiago Karen Murphy VP & Chief Accounting Officer | 2023-08-03 17:21:21 | 9979 0 | 9979 | Form 4 |
Carletti Lorenzo SVP Global Ops Ph & Cons Hlth | 2023-12-12 19:09:14 | 9178 0 | 9178 | Form 4/A |
Ryan Michelle R Director | 2023-10-31 16:28:55 | 8972 0 | 8972 | Form 4 |
DAMELIO FRANK A Director | 2023-10-31 16:59:05 | 7972 0 | 7972 | Form 4 |
Okey Stephanie Director | 2023-10-31 16:24:23 | 7972 0 | 7972 | Form 4 |
Hawkeswood Thomas W Pres. Pharma Prod Delivery Div | 2023-12-12 19:16:02 | 7827 0 | 7827 | Form 4/A |
Barg Steven Director | 2023-10-31 17:08:52 | 7711 0 | 7711 | Form 4 |
Riley Michael A. Pres. Bio Product Delivery Div | 2022-08-30 14:38:01 | 6592 0 | 6592 | Form 4 |
Gargiulo Mario SVP, Ops, Biologics Europe | 2023-05-03 18:58:00 | 5676 0 | 5676 | Form 4 |
Whitlow Ricci S President, CSS | 2022-01-24 16:42:46 | 2923 0 | 2923 | Form 4 |
Blackstone Management Associates V L.L.C. Blackstone Healthcare Partners L.L.C. BLACKSTONE CAPITAL PARTNERS V L P BMA V L.L.C. Blackstone Holdings III L.P. Blackstone Holdings III GP L.P. Blackstone Holdings III GP Management L.L.C. Blackstone Group L.P. Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner | 2017-02-14 14:25:56 | 0 0 | 0 | Form 13G |
Chu Chinh Director | 2014-07-31 20:29:59 | 0 0 | 0 | Form 3 |
McEvoy Bruce Director | 2014-07-31 20:19:30 | 0 0 | 0 | Form 3 |